Stock CUE CUE BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Cue Biopharma, Inc.

Equities

CUE

US22978P1066

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
0.9402 USD -0.85% Intraday chart for Cue Biopharma, Inc. -2.06% -64.39%
Jul. 01 Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 3000E Growth Index CI
Jul. 01 Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 2000 Growth Index CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 3000E Growth Index
CI
Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 2000 Growth Index
CI
Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 2500 Index
CI
Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 3000 Index
CI
Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 2000 Index
CI
Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 3000 Growth Index
CI
Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell Small Cap Comp Growth Index
CI
Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 2000 Dynamic Index
CI
Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell Small Cap Completeness Index
CI
Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 3000E Index
CI
Cue Biopharma, Inc.(NasdaqCM:CUE) dropped from Russell 2500 Growth Index
CI
Cue Biopharma, Inc. Appoints Michael J. Fox to the Board of Directors and the Compensation Committee
CI
Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting
GL
Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting
AQ
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024
GL
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024
AQ
Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
GL
Cue Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
GL
Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CUE Stock
  4. News Cue Biopharma, Inc.